What is Evommune 's change in additional paid in capital?

Evommune (EVMN) reported change in additional paid in capital of $657.06K in Q4 2025.

What does change in additional paid in capital mean?

Measures the net change in the portion of shareholders' equity that exceeds the par value of common stock, typically resulting from equity issuances, share-based compensation, or conversions. This metric provides insight into the company's equity financing history and the dilution impact on existing shareholders. It serves as a key indicator of how the company funds its operations through equity markets.

Evommune EVMN Change In Additional Paid In Capital

Change In Additional Paid In Capital at other companies

New York Mortgage TrustADAM

$2.31B+1.0%

Arthur J. GallagherAJG

$17.64B+0.9%

Nasdaq, Inc.NDAQ

$4.63B-15.1%

Prudential FinancialPRU

$25.95B+0.3%

Royal Caribbean GroupRCL

$7.87B+0.3%

Ubiquiti Inc.UI

$20.83M+35.8%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:ChangeInAdditionalPaidInCapital.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's change in additional paid in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's change in additional paid in capital?: Evommune (EVMN) reported change in additional paid in capital of $657.06K in Q4 2025.
What does change in additional paid in capital mean?: Measures the net change in the portion of shareholders' equity that exceeds the par value of common stock, typically resulting from equity issuances, share-based compensation, or conversions. This metric provides insight into the company's equity financing history and the dilution impact on existing shareholders. It serves as a key indicator of how the company funds its operations through equity markets.